Christian Jacques

Christian Jacques

Celgene Inc. - Summit / United States
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4375914
-
person_outline Christian Jacques's MOST POPULAR ARTICLES
1-) Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerD Cunningham, S Pyrhönen, RD James, CJA Punt, TF Hickish, R Heikkila, ...The Lancet 352 (9138), 1413-1418, 199815441998
2-) Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerP Rougier, E Van Cutsem, E Bajetta, N Niederle, K Possinger, R Labianca, ...The Lancet 352 (9138), 1407-1412, 199812181998
3-) Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label …J San Miguel, K Weisel, P Moreau, M Lacy, K Song, M Delforge, L Karlin, ...The lancet oncology 14 (11), 1055-1066, 20139212013
4-) Lenalidomide and dexamethasone in transplant-ineligible patients with myelomaL Benboubker, MA Dimopoulos, A Dispenzieri, J Catalano, AR Belch, ...New England Journal of Medicine 371 (10), 906-917, 20149472014
5-) Continuous lenalidomide treatment for newly diagnosed multiple myelomaA Palumbo, R Hajek, M Delforge, M Kropff, MT Petrucci, J Catalano, ...New England Journal of Medicine 366 (19), 1759-1769, 20129372012